CALMEPAM TABLETS

GlaxoSmithKline Pharmaceuticals Ltd

Revision date : 2022-03-09

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS07
Health risk rating 4
Safety risk rating 1
Environmental risk rating 5

Note: Ingredients listed on restricted chemical lists

EC/CAS

12227-78-0

Name of the chemical

2′,4′,5′,7′-Tetraiodofluorescein, its disodium salt (Acid Red 51; CI 45430) and its aluminium salt (Pigment Red 172 Aluminium lake) when used as a substance in hair dye products

Concentration

<12 87-<99

General Information

Version

03

Revision date

2022-03-09

Product name

CALMEPAM TABLETS

Product Synonyms

CALMEPAM TABLETS 1.5 MG * CALMEPAM TABLETS 3 MG * BROMAZEPAM, FORMULATED PRODUCT

Manufacturer Name

2_HEADER_HAZARD_IDENTIFICATION

Icons in SDS

GHS07

Company Information

company name

GlaxoSmithKline Pharmaceuticals Ltd

GHS Information

Signal word

Warning

Section 2

SECTION 2: Hazards identification

Physical hazards

Not classified.

Health hazards

Skin corrosion/irritation Category 3 Serious eye damage/eye irritation Category 2

Environmental hazards

Not classified.

Signal word

Warning

Hazard statements

Causes mild skin irritation. Causes serious eye irritation.

Prevention

Wash thoroughly after handling. Wear eye protection/face protection.

Response

IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If skin irritation occurs: Get medical advice/attention. If eye irritation persists: Get medical advice/attention.

Storage

Not available.

Disposal

Dispose of contents/container (in accordance with related regulations).

Other hazards

which do not Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health result in classification hazards.

Additional information

53.35 % of the mixture consists of component(s) of unknown acute oral toxicity. 98.25 % of the mixture consists of component(s) of unknown acute dermal toxicity. 97.05 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 98.25 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.